Oncology

“Unfortunately, limited access to these therapies worldwide appears to be a major challenge,” the researchers wrote.

Tiago Biachi de Castria, MD, PhD, Moffitt Cancer Center

December 18th 2023

Dr Tiago Biachi Discusses Precision Medicine Advancements in Solid Tumors

Pearl Steinzor

Tiago Biachi de Castria, MD, PhD, associate member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center, discusses how precision medicine tools have aided oncologists in treating patients with solid tumors, while reducing overall toxicity.

Highlights ACCC 2023 Annual Meeting and Cancer Center Business Summit

December 15th 2023

ICYMI: Highlights From ACCC Spring 2023

Our most-read coverage from the Association of Community Cancer Centers (ACCC) 2023 Annual Meeting and Cancer Center Business Summit highlighted ongoing issues in oncology policy and practice.

FDA on Paper Texture | Image credit: Araki Illustrations - stock.adobe.com

December 15th 2023

FDA Approves Belzutifan for Advanced RCC After PD-1 or PD-L1 Inhibition and a VEGF-TKI

The approval of belzutifan, an oral hypoxia-inducible factor-2 alpha inhibitor, provides a new option for patients with advanced renal cell carcinoma (RCC) following treatment with a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor and a vascular endothelial growth factor tyrosine kinase inhibitor (VEGF-TKI).

December 12th 2023

ICYMI: Highlights From the 2023 Community Oncology Conference

Our top coverage from this year’s Community Oncology Conference, hosted by the Community Oncology Alliance, included discussions around alternative payment models, shifts in the community oncology landscape in recent decades, and the need for reform in several areas.

stethoscope on charts - amazing studio - stock.adobe.com

December 8th 2023

California Aims for Equity by Redefining Cancer Care

Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.

Quit Smoking - s@photo - stock.adobe.com

December 7th 2023

Research Reveals the Role of Structural Racism in Lung Cancer Risk

Spanning 22 studies, the analysis illuminated housing disparities, occupational hazards, unequal health care access, economic inequality, and discriminatory industry practices and how they collectively contribute to heightened lung cancer risks.

December 2nd 2023

FDA Grants Priority Review to Enfortumab Vedotin + Pembrolizumab in Metastatic Urothelial Cancer

Jordyn Sava

Positive data from the phase 3 EV-302 trial of enfortumab vedotin with pembrolizumab in locally advanced or metastatic urothelial cancer have shifted the landscape.

Hospital | Image credit: Andrii - stock.adobe.com

December 1st 2023

Gaps in Access to Cancer Care Resources May Contribute to Racial, Ethnic Disparities

Researchers found that core oncology services were less likely to be available at hospitals serving racial and ethnic minority groups compared with other hospitals in the United States.

empty prescription bottle | Image credit: Diomedes de jesus - stock.adobe.com

November 21st 2023

IQVIA Report Spotlights Shortages for Pain, Obesity, and Oncology Therapies

Skylar Jeremias

A new report from IQVIA provides an overview of current US drug shortages, shedding light on major areas of concern, such as medications to address pain, cardiovascular conditions, obesity and diabetes, and multiple forms of cancer.

November 17th 2023

Dr Alyson Moadel-Robblee on Effective Distress Screening and Support Systems for Patients With Cancer

Pearl Steinzor Rose McNulty

Alyson Moadel-Robblee, PhD, deputy director of community engagement and cancer health equity at Montefiore Einstein Comprehensive Cancer Center, discussed the center's evolving patient distress screening process and the Bronx Oncology Living Daily support program for patients with cancer.

November 16th 2023

Nashville Oncology Associates Now Part of The US Oncology Network

The US Oncology Network now has more than 2400 providers who treat over 1.4 million patients annually at approximately 600 sites of care in 30 states.

Ian Flinn, MD, PhD | Image credit: Tennessee Oncology

November 16th 2023

Ian Flinn, MD, PhD, to Serve as Chief Scientific Officer for Greco-Hainsworth Tennessee Oncology Centers for Research

AJMC Staff

The centers for research are named for Anthony Greco, MD, and John Hainsworth, MD, who founded Sarah Cannon in 1993 as Tennessee Oncology physician researchers.

Female patient and doctor - Dragana Gordic - stock.adobe.com

November 14th 2023

Racial Discrimination in Cancer Care Has Long-Term Impact on Patients, Study Shows

“The silencing of Black cancer patient voices impacted patients’ health care utilization and had implications for their physical health,” the authors wrote.

November 10th 2023

Overcoming Challenges to Value-Based Care Implementation: Grant Andres

In an interview with The American Journal of Managed Care®, Grant Andres, BSc, DC, BSN, MSN-RN, senior director of clinical operations at Arizona Oncology, discussed the nuances of successfully implementing value-based care initiatives across a large organization.

November 2nd 2023

Dr Amy Laughlin on the Benefits of At-Home Cancer Care

Amy Laughlin, MD, MSHP, of Orlando Health gave a preview of the topic she is presenting on at today's American Journal of Managed Care®’s Institute for Value-Based Medicine® event in New York City.

November 1st 2023

Dr Kathi Mooney Previews Oncology Hospital at Home Presentation

Kathi Mooney, PhD, RN, FAAN, of the University of Utah, gave a preview of "The Oncology Hospital at Home," the presentation she is giving at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on November 2 in New York City.

October 30th 2023

Dr Saira Jan Details Current, Future Cost Savings From Oncology Therapeutics Home Infusion Program

Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey, discussed cost savings that occurred so far from their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health and also noted those they predict to occur as the program continues.

October 27th 2023

Collaboration Is Key to Execute Value-Based Care for Patients With Cancer

Coverage of the Institute for Value-Based Medicine session with Zangmeister Cancer Center, Columbus, Ohio.

October 27th 2023

Dr Saira Jan Explains Oncology Therapeutics Home Infusion Pilot Program

Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey, provides an overview of their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health, discussing the program's origin, objectives, and beyond.

October 26th 2023

Multiple Perspectives of Managing Cancer From the Multidisciplinary Team at Vanderbilt

Laura Joszt, MA

Coverage from the Institute for Value-Based Medicine event with Vanderbilt University Medical Center.

October 26th 2023

Raising the Bar for Precision Oncology and Clinical Research in a Community Practice Setting

Mary Caffrey

Coverage from the Institute for Value-Based Medicine session with Florida Cancer Specialists & Research Institute.

October 25th 2023

Business Highlights From Partners in Community Oncology

AJMC Staff

October 25th 2023

OneOncology Finalizes 25 Clinical Pathways in Oncology and Hematology

AJMC Staff

October 25th 2023

COA’s Policy Agenda Gains Steam on Capitol Hill, as the House Elects a Speaker

Mary Caffrey

There is bipartisan support in the Congress for the Community Oncology Alliance's (COA) key agenda items, with hope that some will pass by year’s end.

Ted Okon, MBA, Community Oncology Alliance

October 25th 2023

Innovating Community Oncology Care Delivery and Payment Reform: Insights From COA’s Ted Okon

Ted Okon, MBA, executive director, Community Oncology Alliance, discusses early returns from the Enhancing Oncology Model and how community oncology practices are innovating in ways that can expand into other areas of medicine.

Miriam J. Atkins, MD, FACP, Community Oncology Alliance/AO Multispecialty Clinic

October 24th 2023

Dr Miriam J. Atkins: Each One of Us Needs Everyone Else

Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance, discusses the challenges facing oncology today, such as physician and nurse recruitment and minority clinical trial enrollment.

October 23rd 2023

Dr Lalan Wilfong: Patients Deserve the Full Benefit of Everything We Can Provide

At the 2023 COA Payer Exchange Summit being held October 23-24 in Reston, Virginia, Lalan Wilfong, MD, US Oncology Network, emphasizes the importance of oncology care equity, ensuring continuity of care, and enhancing care coordination.

Stomach cancer art | Image credit: Crystal light - stock.adobe.com

October 20th 2023

Frontline Pembrolizumab Plus Trastuzumab/Chemotherapy Improves PFS in HER2+ Gastric/GEJ Cancer

Ryan Scott

Adding pembrolizumab to combination of trastuzumab and chemotherapy improved progression-free survival vs placebo plus trastuzumab and chemotherapy in the first-line treatment of patients with metastatic HER2-positive gastric or gastroesophageal junction (GEJ) cancer.

noted Joelle Hicks, BSN, RN | Image Credit: Summa Health

October 17th 2023

Streamlined Referral Intervention Sees Great Success Among Patients With Head/Neck Cancer